Last Price
101.88
Today's Change
-0.44 (0.43%)
Day's Change
101.21 - 102.72
Trading Volume
8,505,308
Market Cap
258 Billion
Shares Outstanding
2 Billion
Avg Volume
9,389,359
Avg Price (50 Days)
112.55
Avg Price (200 Days)
122.17
PE Ratio
21.31
EPS
4.78
Earnings Announcement
04-Feb-2025
Previous Close
102.32
Open
101.78
Day's Range
101.215 - 102.72
Year Range
98.6 - 134.63
Trading Volume
7,242,103
1 Day Change
-0.43%
5 Day Change
-2.60%
1 Month Change
-7.53%
3 Month Change
-11.56%
6 Month Change
-20.10%
Ytd Change
-10.03%
1 Year Change
-1.45%
3 Year Change
14.88%
5 Year Change
27.35%
10 Year Change
81.35%
Max Change
25668.27%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—General
Description:
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.